# Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation

Study · id `cardio:ct-nct03807037` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03807037](<https://clinicaltrials.gov/study/NCT03807037>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03807037

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.

## Technical summary

Registry record NCT03807037. Randomized; triple masking; primary purpose prevention. Start 2018-12-17 (actual); primary completion 2021-12-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 2/3
- Enrolled: 250 participants (enrolled count; ClinicalTrials.gov record NCT03807037, source copy `cardio:ctgov-nct03807037-2022-08-25`, retrieved 2026-10-26)
- Started: 2018-12-17 (actual) (ClinicalTrials.gov record NCT03807037, source copy `cardio:ctgov-nct03807037-2022-08-25`, retrieved 2026-10-26)
- Primary completion: 2021-12-30 (actual) (ClinicalTrials.gov record NCT03807037, source copy `cardio:ctgov-nct03807037-2022-08-25`, retrieved 2026-10-26)
- Completion: 2021-12-30 (actual) (ClinicalTrials.gov record NCT03807037, source copy `cardio:ctgov-nct03807037-2022-08-25`, retrieved 2026-10-26)
- Countries: Malaysia (ClinicalTrials.gov record NCT03807037, source copy `cardio:ctgov-nct03807037-2022-08-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03807037-2022-08-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation
- Condition: Atrial Fibrillation
- Intervention (Dietary supplement): Tocotrienols
- Intervention (Drug): Placebo oral capsule
- Lead sponsor: Monash University Malaysia
- Lead sponsor class: OTHER
- Collaborator: Institut Jantung Negara
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 43bcdc9864f77bb0fe2b8b3ea620e9507808dd3eceac2b6bd89709568b3e118c
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
